Skip to main content
Clinical Trials/NCT05389670
NCT05389670
Not yet recruiting
Not Applicable

Theta-burst Repetitive Transcranial Magnetic Stimulation (TBS) of the Right Inferior Frontal Gyrus for Treatment of Nicotine Dependence

University of Missouri-Columbia0 sites60 target enrollmentJuly 1, 2025

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Tobacco Use Disorder
Sponsor
University of Missouri-Columbia
Enrollment
60
Primary Endpoint
Change in the number (#) of cigarettes per day.
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

The purpose of this research study is to examine the effects of theta-burst Transcranial Magnetic Stimulation on inhibitory control and smoking among adult cigarette smokers. In a double-blind, sham controlled trial, investigators will examine the effects of 12 sessions of cTBS on executive function and smoking behavior.

Registry
clinicaltrials.gov
Start Date
July 1, 2025
End Date
April 1, 2026
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Brett Froeliger

Professor

University of Missouri-Columbia

Eligibility Criteria

Inclusion Criteria

  • 18-65 yrs. of age
  • Smoke \> 5 cigarettes/day for ≥ 2 yrs, and expired carbon monoxide (CO) concentration of ≥ 8 ppm
  • English Fluency
  • Functional Vision (with corrective lenses as needed)

Exclusion Criteria

  • Use of psychotropic and antiepileptic medications in the last month
  • Presence of an untreated illness or serious medical condition
  • History of major neurological illness
  • Contraindication to TMS (history of neurological disorder or seizure, increased intracranial pressure, brain surgery, or head trauma with loss of consciousness for \>15 min., implanted electronic device, metal in the head)
  • Any use of substances that lower seizure threshold
  • Current or past psychosis
  • Electroconvulsive therapy in last 6 months
  • Unstable cardiac disease or hypertension, severe renal or liver insufficiency, or sleep apnea
  • BAC greater than 0.
  • Positive urine pregnancy test

Outcomes

Primary Outcomes

Change in the number (#) of cigarettes per day.

Time Frame: 2 months

The effects of 12 sessions of continuous theta burst stimulation (cTBS) to the right inferior frontal gyrus (r.IFG) on cigarettes per day (CPD). This is measured by a core daily cigarette diary and will be measured following treatment and after making a quit attempt at: days 14, 21 and 28.

Cigarette craving scores (#) as measured by the questionnaire of smoking urges brief (QSUb).

Time Frame: 2 months

The effects of 12 sessions of continuous theta burst stimulation (cTBS) to the right inferior frontal gyrus (r.IFG) on cigarette craving. This will be measured at the end of every visit to the laboratory. The Questionnaire of Smoking Urges brief (QSUb) rages from 0 to 70. Lower scores equal less craving, meaning the lower the score, the better the outcome.

Percent (%) correct on an inhibitory control GoGo/NoGo task.

Time Frame: 2 months

The effects of 12 sessions of continuous theta burst stimulation (cTBS) to the right inferior frontal gyrus (r.IFG) on inhibitory control (IC) task performance. This will be measured at : baseline; after completing 12 sessions of cTBS treatment, 3-7 days following making a quit attempt and at days 14, 21 and 28 following quit attempt.

Craving regulation scores (#) on a regulation of craving task.

Time Frame: 2 months

The effects of 12 sessions of continuous theta burst stimulation (cTBS) to the right inferior frontal gyrus (r.IFG) on regulation of craving (ROC) task performance. This will be measured at : baseline; after completing 12 sessions of cTBS treatment, 3-7 days following making a quit attempt and at days 14, 21 and 28 following quit attempt.

Secondary Outcomes

  • Symptoms scores (#) as measured by the review of symptoms (ROS) questionnaire.(2 months)

Similar Trials